CT SB00925 | 2017 | General Assembly
Status
Spectrum: Committee Bill
Status: Introduced on February 24 2017 - 25% progression, died in chamber
Action: 2017-03-30 - File Number 345
Text: Latest bill text (Comm Sub) [HTML]
Status: Introduced on February 24 2017 - 25% progression, died in chamber
Action: 2017-03-30 - File Number 345
Text: Latest bill text (Comm Sub) [HTML]
Summary
To: (1) Require manufacturers of prescription drugs to disclose pricing information to the Insurance Commissioner; (2) require that certain insurance policies incorporate value-based insurance design; and (3) establish a task force to study methods of controlling the cost of prescription drugs.
Title
An Act Concerning The Cost Of Prescription Drugs And Value-based Insurance Design.
Sponsors
Roll Calls
2017-03-15 - Joint - INS Vote Tally Sheet (House) (Y: 9 N: 8 NV: 0 Abs: 0) [PASS]
2017-03-15 - Joint - INS Vote Tally Sheet (Senate) (Y: 1 N: 3 NV: 0 Abs: 0) [FAIL]
2017-03-15 - Joint - INS Vote Tally Sheet (Senate) (Y: 1 N: 3 NV: 0 Abs: 0) [FAIL]
History
| Date | Chamber | Action |
|---|---|---|
| 2017-03-30 | Senate | File Number 345 |
| 2017-03-30 | Senate | House Calendar Number 252 |
| 2017-03-30 | Senate | Tabled for the Calendar, House |
| 2017-03-30 | Senate | Favorable Report, House Committee on Insurance and Real Estate |
| 2017-03-30 | Senate | Reported Out of Legislative Commissioners' Office |
| 2017-03-24 | Senate | Referred to Office of Legislative Research and Office of Fiscal Analysis 03/29/17 5:00 PM |
| 2017-03-16 | Senate | Filed with Legislative Commissioners' Office |
| 2017-03-15 | Senate | House Favorable Substitute |
| 2017-03-15 | Senate | Motion Failed SF |
| 2017-03-03 | Senate | Public Hearing 03/07 |
| 2017-02-24 | Senate | Referred to Joint Committee on Insurance and Real Estate |
